晚期肺腺癌易瑞沙治疗病例介绍并文献复习
摘要
近50年来,肺癌的发病率和病死率均迅速上升,世界各国特别是工业发达国家,死于癌症的男性患者中肺癌已居首位。在非小细胞肺癌（Non-small cell lung cancer,NSCLC）中,肺腺癌已成为最常见的病理类型,多数患者确诊时已是晚期,
出处
《中国实用医药》
2011年第29期182-183,共2页
China Practical Medicine
参考文献11
-
1Kaneda H,Tamura K,Kurata T,et al.Retrospective analysis of the predictive factors associated with the response and survival be-nefitof gefitinib in patients with advanced non-small cell lung canc-er. Lung Cancer . 2004
-
2Herbst RS,Kies MS.ZD1839 ( IressaTM ) in non-small-cell lung cancer. The Oncologist . 2002
-
3Yarden Y,Sliwkowski MX.Untangling the ErbB signalling network. Nature Reviews Molecular Cell Biology . 2001
-
4Fukuoka M,Yano S,Giaccone G,et al.Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer. Journal of Clinical Oncology . 2003
-
5Kris MG,Natale RB,Herbst RS,et al.Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. The Journal of The American Medical Association . 2003
-
6Giaccone G,Herbst RS,Manegold C,et al.Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase Ⅲ trial-INTACT 1. Journal of Clinical Oncology . 2004
-
7Herbst RS,Giaccone G,Schiller JH,et al.Gefitinib in combination with paclitaxel and carboplatin in advanced non-small cell lung cancer: a phase Ⅲ trial-INTACT2. Journal of Clinical Oncology . 2004
-
8Pao W,Miller VA.Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions. Journal of Clinical Oncology . 2005
-
9ArgirisA,MittalN.Gefitinibasfirst linecompassionateusetherapyinpatientswithadvancednon small celllungcancer. Lung Cancer . 2004
-
10Hsieh RK,Lim KH,Kuo HT,et al.Female sex and bronchi alveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer. Chest . 2005
-
1郭庆志,王洁.肺癌？肺癌！[J].大众健康,2007(4):84-90.
-
2陈艺华.癌基因、抗癌基因异常与人乳腺癌[J].中华病理学杂志,1994,23(2):122-124. 被引量：12
-
3罗彤,曹盛生.肺癌手术患者真菌医院感染的情况分析及护理[J].中国实用护理杂志,2011,27(8):61-62. 被引量：2
-
4李洪波.肿瘤标志物检测对非小细胞肺癌预后判断及疗效监测的意义[J].海南医学院学报,2012,18(10):1504-1506. 被引量：9
-
5黄昌杰.异长春花碱治疗非小细胞肺癌研究进展[J].广西医学,2002,24(8):1207-1209.
-
6刘长飞,雷威,刘建伟,赵志国,黄冬梅.肺癌肿瘤标记物的表达及其临床意义[J].中国综合临床,2013,29(4):442-443. 被引量：8
-
7袁志平,屈小琴,牟华平,彭生才.外科手术在卵巢肿瘤诊治中的作用[J].重庆医学,2008,37(18):2113-2116.
-
8肖祥胜,夏旭.肺癌免疫抑制机制研究[J].广东医学,2002,23(3):320-322. 被引量：2
-
9李智.晚期肺癌介入治疗的护理配合[J].内科,2007,2(6):1029-1030. 被引量：1
-
10章静波.《结肠直肠癌》[J].国外医学情报,2003,24(4):47-48.
